![]() United States Ultrasound Devices Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033
United States Ultrasound Devices Market Trends & Summary United States Ultrasound Devices market is expected to reach US$ 4.36 billion by 2033 from US$ 2.75 billion in 2024, with a CAGR of 5.27%... もっと見る
SummaryUnited States Ultrasound Devices Market Trends & SummaryUnited States Ultrasound Devices market is expected to reach US$ 4.36 billion by 2033 from US$ 2.75 billion in 2024, with a CAGR of 5.27% from 2025 to 2033. The US market is dominated by factors like the aging population, developing technologies, shifting patient care approaches, and changing epidemiological patterns. Additionally, there is a strong need for imaging technologies like ultrasounds due to the rising prevalence of chronic illnesses like breast cancer, cardiovascular conditions, and neurological ailments. The report United States Ultrasound Devices Market & Forecast covers by Products (Diagnostics Ultrasound and Therapeutic Ultrasound), Portability (Trolley/Cart-based Ultrasound Devices and Compact/Handheld Ultrasound Devices), Application (Radiology/General Imaging, Cardiology, Gynecology, Vascular, Urology, and Others), End-Users (Hospitals, Surgical Centers, Diagnostic Centers, Maternity Centers, Ambulatory Care Centers, and Academic Institutions), and Company Analysis 2025-2033. United States Ultrasound Devices Industry Overview Advances in imaging technology, the growing need for non-invasive diagnostic tools, and an older population with greater healthcare needs are all contributing to the strong growth of the US ultrasound device market. Because they may give real-time imaging with little discomfort to the patient, ultrasound equipment is frequently employed in a variety of medical specialties, including obstetrics, cardiology, orthopedics, and emergency care. The capabilities and accessibility of ultrasound systems have been significantly enhanced by technological advancements including 3D/4D ultrasound, portable handheld devices, and AI integration. The market is also expanding due to the move to point-of-care diagnostics and the growing use of ultrasonography in outpatient settings. The industry's growth in the United States is also being aided by government initiatives, increased awareness of early disease identification, and rising healthcare costs. The market is expected to grow as a result of frequent product debuts that provide enhanced imaging, productivity, and ergonomic capabilities. To create technologically sophisticated products, major firms are investing in a number of R&D initiatives. For example, FUJIFILM SonoSite, Inc. introduced Sonosite ST in July 2023. It features an all-touch 21-inch touchscreen, a 10" by 7.5" picture area, Auto Steep Needle Profiling (SNP), and automated setting optimization for every test type. Likewise, to improve their market position, a number of industry participants are purchasing smaller competitors. Businesses can enhance their expertise, diversify their product offerings, and boost their capabilities with this approach. For example, NXC Imaging, a Minneapolis, Minnesota-based producer of medical devices and services, was acquired by Canon Medical Systems Corporation in July 2022. Growth Drivers for the United States Ultrasound Devices Market Growing Need for Small Devices to Accelerate Market Development Compact ultrasound systems are becoming more and more popular in healthcare settings because of their many potential advantages over conventional systems, including portability, affordability, non-invasiveness, and improved imaging outcomes. Further driving the growth of the U.S. market will be the increasing product introductions of compact systems by major manufacturers over widespread clinical applications nationwide. The U.S. Food and Drug Administration (FDA) approved Koninklijke Philips N.V.'s 5000 series small ultrasound system in September 2022 for use in obstetrics & gynecology, cardiology, general imaging, and point of care. Rising Prevalence of Chronic Diseases The increased frequency of chronic diseases, such as cardiovascular ailments, cancer, and musculoskeletal issues, is considerably driving the need for ultrasound devices in the United States. Early detection and ongoing monitoring are essential for efficient management and treatment of many disorders as their occurrence rises. Due to its non-invasive nature, real-time imaging capabilities, and radiation-free capacity to detect abnormalities, ultrasound is a favored diagnostic tool for ailments like heart disease, cancer (particularly liver and breast cancer), and joint issues. Ultrasound is also widely available and reasonably priced, which makes it perfect for regular screenings and follow-ups. The market is anticipated to continue growing as the frequency of chronic diseases rises and there is a greater need for ultrasound equipment, especially in the areas of early-stage identification and continuous monitoring. Rise in Government Initiatives The growing usage of ultrasound equipment in the US is being driven by government initiatives aimed at enhancing early diagnosis, disease prevention, and healthcare access. More individuals are now able to receive basic examinations, such as ultrasound imaging, thanks to policies like the Affordable Care Act (ACA), which have increased access to healthcare. The use of non-invasive diagnostic techniques, like ultrasonography, for early disease diagnosis is also encouraged by government programs and financing for preventive care, especially in high-risk groups. The use of ultrasound for monitoring and diagnostics is also encouraged by federal and state programs aimed at preventing cancer, managing chronic diseases, and improving maternal health. The market is expanding overall as a result of these rules and rising awareness of the value of early detection, which are encouraging the use of ultrasonography in both routine checkups and emergency care. Challenges in the United States Ultrasound Devices Market Competition from Other Imaging Technologies The market for ultrasound devices is challenged by competition from alternative imaging methods, such as CT and MRI scans. CT and MRI scans offer higher-resolution images, making them the recommended option for specific diagnostic applications, such as sophisticated neurological, cardiac, and oncological imaging, even though ultrasound is less expensive, non-invasive, and radiation-free. CT and MRI are frequently more dependable and accurate in domains where precise, high-quality imaging is essential, such as brain imaging or tumor identification. This restricts the use of ultrasonography in specific diagnostic fields. Furthermore, the advantages of ultrasonography can occasionally be overshadowed by the wider variety of capabilities that MRI and CT scanners offer for more thorough internal structural assessments, especially in more complicated or urgent cases. Ultrasound is therefore up against competition in specialized applications and high-resolution imaging. Technological integration of advanced ultrasound systems There are many obstacles in integrating cutting-edge ultrasound technologies, like 3D imaging and AI-driven diagnostics, into the current hospital infrastructure. These advancements frequently call for the replacement or improvement of legacy systems and necessitate significant hardware and software upgrades. For instance, integrating AI-powered diagnostic tools necessitates not just setting up appropriate hardware but also building a strong data infrastructure that can efficiently collect and process massive amounts of imaging data. Healthcare personnel also need to be retrained to use these sophisticated tools and decipher their increasingly complicated outputs, such 3D models or AI-assisted diagnostic recommendations. The adoption of these innovative ultrasonography technologies may be slowed down by the time-consuming and expensive nature of this process, especially in smaller clinics or hospitals with fewer resources. The US ultrasound equipment industry is seeing a rise in the usage of therapeutic ultrasound Therapeutic ultrasound is poised for an increase within the United States ultrasound device market. This is due to its expanding packages throughout ache management, bodily therapy, and sports medication. As the population's life lasts longer and becomes more active, there is a rising demand for non-invasive treatments to alleviate musculoskeletal disorders and injuries. Therapeutic ultrasound offers a centered remedy, promoting tissue recovery and rehabilitation. With technological improvements and growing awareness of its benefits, the market for therapeutic ultrasound in the US is expected to flourish. The most often used ultrasound equipment in the US market are those that are mounted on trolleys or carts Trolley/cart-based ultrasound devices dominate the US market. This is because of their versatility, superior imaging skills, and substantial scientific applications. They provide excessive-decision imaging and cater to numerous clinical specialties, including obstetrics, cardiology, and oncology. These systems offer more advantageous features, including advanced Doppler and 3-D/4D imaging, critical for accurate diagnoses and remedy planning. Moreover, their ergonomic layout and mobility enable green workflow in hospitals and clinics. As healthcare carriers prioritize performance and versatility, trolley/cart-based ultrasound devices stay desired within the United States ultrasound device market. In the US, the market for ultrasound devices is dominated by radiology and general imaging Radiology/general imaging commands the most significant share of the US ultrasound device market. This is owed to its wide range of diagnostic applications throughout numerous scientific specialties. From assessing abdominal and pelvic situations to diagnosing musculoskeletal and vascular problems, radiology/general imaging ultrasound is a flexible tool for healthcare companies. With advancements like high-frequency probes and comparison-improved imaging, these structures offer better diagnostic accuracy. The developing occurrence of continual diseases necessitates frequent imaging, further propelling the need for radiology/general ultrasound devices in the US. United States hospitals will dominate the ultrasound device market Hospitals are poised to keep their leadership within the ultrasound device market in the United States. This is because they are the number one care providers and centers of clinical excellence. With an extensive range of specialties and patient populations, hospitals require versatile ultrasound structures for diagnostics, tracking, and interventions. Moreover, technological improvements, which include portable and point-of-care ultrasound gadgets, enhance their efficiency and utility within clinical settings. As hospitals prioritize quality care and technological innovation, they're predicted to maintain their dominance in the US ultrasound device market. Products – Market breakup in 2 viewpoints: 1. Diagnostics Ultrasound 2. Therapeutic Ultrasound Portability – Market breakup in 2 viewpoints: 1. Trolley/Cart-based Ultrasound Devices 2. Compact/Handheld Ultrasound Devices Application – Market breakup in 6 viewpoints: 1. Radiology/General Imaging 2. Cardiology 3. Gynecology 4. Vascular 5. Urology 6. Others End-Users – Market breakup in 6 viewpoints: 1. Hospitals 2. Surgical Centers 3. Diagnostic Centers 4. Maternity Centers 5. Ambulatory Care Centers 6. Academic Institutions All the Key players have been covered from 3 Viewpoints: • Overview • Recent Development • Revenue Analysis Company Analysis: 1. GE Healthcare 2. Healthcare Hologic Inc. 3. Butterfly Network 4. Hitachi Healthcare Americas 5. Samsung Electronics Co.Ltd 6. Hologic, Inc. 7. Fujifilm Holdings Corporation Table of Contents1. Introduction2. Research & Methodology 3. Executive Summary 4. Market Dynamics 4.1 Growth Drivers 4.2 Challenges 5. United States Ultrasound Device Market 6. Market Share 6.1 By Products 6.2 By Portability 6.3 By Application 6.4 By End User 7. Products 7.1 Diagnostics Ultrasound 7.2 Therapeutic Ultrasound 8. Portability 8.1 Trolley/Cart-based Ultrasound Devices 8.2 Compact/Handheld Ultrasound Devices 9. Application 9.1 Radiology/General Imaging 9.2 Cardiology 9.3 Gynecology 9.4 Vascular 9.5 Urology 9.6 Others 10. End-user 10.1 Hospitals 10.2 Surgical Centers 10.3 Diagnostic Centers 10.4 Maternity Centers 10.5 Ambulatory Care Centers 10.6 Academic Institutions 11. Porter’s Five Forces 11.1 Bargaining Power of Buyers 11.2 Bargaining Power of Suppliers 11.3 Degree of Competition 11.4 Threat of New Entrants 11.5 Threat of Substitutes 12. SWOT Analysis 12.1 Strength 12.2 Weakness 12.3 Opportunity 12.4 Threat 13. Key Players Analysis 13.1 GE Healthcare 13.1.1 Overview 13.1.2 Recent Development 13.1.3 Revenue 13.2 Healthcare HologicInc 13.2.1 Overview 13.2.2 Recent Development 13.2.3 Revenue 13.3 Butterfly Network 13.3.1 Overview 13.3.2 Recent Development 13.3.3 Revenue 13.4 Hitachi Healthcare Americas 13.4.1 Overview 13.4.2 Recent Development 13.4.3 Revenue 13.5 Samsung Electronics Co.Ltd 13.5.1 Overview 13.5.2 Recent Development 13.5.3 Revenue 13.6 Hologic, Inc. 13.6.1 Overview 13.6.2 Recent Development 13.6.3 Revenue 13.7 Fujifilm Holdings Corporation 13.7.1 Overview 13.7.2 Recent Development 13.7.3 Revenue
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
Renub Research社のヘルスケア分野での最新刊レポート
本レポートと同じKEY WORD(devices)の最新刊レポート
よくあるご質問Renub Research社はどのような調査会社ですか?Renubリサーチ (Renub Research)は、インドに本社を置く調査会社です。通信や医薬市場について、市場動向や技術はもちろん、企業レポートや医療観光(メディカルツーリズム)など、幅広い関連... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|